Clinical Trial

Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.

Study acronym: AlisNEC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the frequency of allergy between 12 and 24 months of age in infants who were treated in the neonatal clinic and had NEC. To investigate the relationship between NEC development and the development of allergy in the later period.
Trial Details
NCT Number NCT07562009
Lead Sponsor Saglik Bilimleri Universitesi
Conditions Necrotizing Enterocolitis, Allergy, Preterm
Enrollment 130 participants
Start Date 2026-04-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01